IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Calidi Biotherapeutics Inc

CUSIP: 320703119 | 46 institutional holders

Quarters

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2024

Exos Asset Management LLC105,000
0.2% of portfolio›$1.0K
StyleTurnoverLocationFiled
Exos Asset Management LLC
105,000$1.0K0.2%Deep ValueVery LowPelham, NY2025-02-13